CNM Core & Main
Core & Main earnings company data as of 4:49 AM ET 10/22
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q4 | 8 Dec | EPS | 0.89 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 9 Sep | EPS | 0.91 | 0.94 | Beat +3.3% |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CNM's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $195K bought by 1 insider
- None no sales outside a trading plan
- $263K sold by 1 insider under 10b5-1 plans
-
James D Hope DirectorBuy$95K 2,067 shares at $46.01 +21% to stakeTraded Jul 6 Filed Jul 8
-
Robyn L Bradbury CFOPlanned sale$263K 5,000 shares at $52.54 29% of stakeTraded Apr 17 Filed Apr 21
-
James D Hope DirectorBuy$100K 1,972 shares at $50.70 +40% to stakeTraded Apr 7 Filed Apr 9
Also filed in the last 12 months, not counted as buying or selling: 25 share withholdings for taxes, 18 stock grants, 1 conversion, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 19 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.